Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Ortho outlook: Device makers gain as Biomet reports 7% increase in U.S. sales
Fellow orthopedic device makers see Wall Street boosts as market bellwether Biomet forecasts 7% U.S. sales growth and 12% international growth in its preliminary 4th quarter and full-year results.
2. Appeals court uphold Boston Scientific win in shareholders’ CRM suit
A federal appeals court upholds the dismissal of a shareholders’ lawsuit filed over statements it made concerning its cardiac rhythm management business.
1. J&J’s Q2 medical device sales stay flat
Sales for Johnson & Johnson’s medical device & diagnostics division were flat, with all units except its orthopedics and specialty surgery segments posting declines.
